| Identification | Back Directory | [Name]
2-Naphthalenol, 5-chloro-4-[4-(3,8-diazabicyclo[3.2.1]oct-3-yl)-8-fluoro-2-[[(2R,7aS)-2-fluorotetrahydro-1H-pyrrolizin-7a(5H)-yl]methoxy]pyrido[4,3-d]pyrimidin-7-yl]- | [CAS]
2621928-53-6 | [Synonyms]
KRAS G12D inhibitor 5
2-Naphthalenol, 5-chloro-4-[4-(3,8-diazabicyclo[3.2.1]oct-3-yl)-8-fluoro-2-[[(2R,7aS)-2-fluorotetrahydro-1H-pyrrolizin-7a(5H)-yl]methoxy]pyrido[4,3-d]pyrimidin-7-yl]- | [Molecular Formula]
C31H31ClF2N6O2 | [MOL File]
2621928-53-6.mol | [Molecular Weight]
593.07 |
| Hazard Information | Back Directory | [Uses]
KRAS G12D inhibitor 5 is a KRAS G12D inhibitor for the potential research of pancreatic cancer. | [References]
[1] Kargbo RB. Targeting KRAS G12D Mutant for the Potential Treatment of Pancreatic Cancer. ACS Med Chem Lett. 2021 Oct 19;12(11):1643-1645. DOI:10.1021/acsmedchemlett.1c00545 |
|
|